MedTrace Logo

Cardiovascular Assessment of Pediatric Cancer Survivors

NCT05939089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2023-07-11

No results posted yet for this study

Summary

The goal of this observational study is to evaluate cardiac and vascular health status of pediatric cancer survivors.

Conditions

Interventions

DIAGNOSTIC_TEST

ECG, Echocardiography, cTnI, NT-ProBNP

All pediatric cancer survivors are evaluated with cardiological examination, ECG, transthoracic echocardiography (transesophageal echocardiography when required), NT-proBNP, cTnI, kidney function tests, liver function tests, fasting blood glucose, cholesterol panel, iron, iron binding capacity, ferritin, transferrin saturation, B12, vitamin D, folic acid, urinanalysis, hemogram and a questionnaire about living with heart failure.

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Cafer Zorkun, MD PhD · Faculty member

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-06-15
Completion
2023-06-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05939089 on ClinicalTrials.gov